HOME > 研究業績 > 2018年- 英語論文

2018年- 英語論文

1.Okamura N, Harada R, Ishiki A, Kikuchi A, Nakamura T, Kudo Y. The development and validation of tau PET tracers: current status and future directions. Clin Transl Imaging. 2018;6(4):305-316.

2.Kobayashi R, Hayashi H, Kawakatsu S, Ishiki A, Okamura N, Arai H, Otani K. [18F]THK-5351 PET imaging in early-stage semantic variant primary progressive aphasia: a report of two cases and a literature review. BMC Neurol. 2018 Aug 8;18(1):109.

3.Ishiki A, Harada R, Kai H, Sato N, Totsune T, Tomita N, Watanuki S, Hiraoka K, Ishikawa Y, Funaki Y, Iwata R, Furumoto S, Tashiro M, Sasano H, Kitamoto T, Kudo Y, Yanai K, Furukawa K, Okamura N, Arai H. Neuroimaging-pathological correlations of [18F]THK5351 PET in progressive supranuclear palsy. Acta Neuropathol Commun. 2018 Jun 29;6(1):53.

4.Brendel M, Schonecker S, Hoglinger G, Lindner S, Havla J, Blautzik J, Sauerbeck J, Rohrer G, Zach C, Vettermann F, Lang AE, Golbe L, Nubling G, Bartenstein P, Furukawa K, Ishiki A, Botzel K, Danek A, Okamura N, Levin J, Rominger A. [18F]-THK5351 PET Correlates with Topology and Symptom Severity in Progressive Supranuclear Palsy. Front. Aging Neurosci., 17 January 2018.

5.Harada R, Ishiki A, Kai H, Sato N, Furukawa K, Furumoto S, Tago T, Tomita N, Watanuki S, Hiraoka K, Ishikawa Y, Funaki Y, Nakamura T, Yoshikawa T, Iwata R, Tashiro M, Sasano H, Kitamoto T, Yanai K, Arai H, Kudo Y, Okamura N. Correlations of 18F-THK5351 PET with Postmortem Burden of Tau and Astrogliosis in Alzheimer Disease. J Nucl Med. 2018 Apr;59(4):671-674.

6.Tomita N, Kojima T, Ishiki A, Ueda J, Numasaki M, Okinaga S, Akishita M, Arai H. Could problem lists summarize comprehensive geriatric assessments? A nationwide cross-sectional survey on geriatricians' attitudes towards problem lists. Geriatr. Gerontol. Int. 19(2), 159-164, 2019. doi: 10.1111/ggi.13574. Epub 2018 Dec 16.

7.Tsukamoto H, Takeuchi S, Kubota K, Kobayashi Y, Kozakai S, Ukai I, Shichiku A, Okubo M, Numasaki M, Kanemitsu Y, Matsumoto Y, Nochi T, Watanabe K, Aso H, Tomioka Y. Lipopolysaccharide (LPS)-binding protein stimulates CD14-dependent Toll-like receptor 4 internalization and LPS-induced TBK1-IKK?-IRF3 axis activation. J. Biol. Chem. 293(26), 10186-10201, 2018.

8.Iwata A, Iwatsubo T, Ihara R, Suzuki K, Matsuyama Y, Tomita N, Arai H, Ishii K, Senda M, Ito K, Ikeuchi T, Kuwano R, Matsuda H; Alzheimer's Disease Neuroimaging Initiative; Japanese Alzheimer’s Disease Neuroimaging Initiative. Effects of sex, educational background, and chronic kidney disease grading on longitudinal cognitive and functional decline in patients in the Japanese Alzheimer's Disease Neuroimaging Initiative study. Alzheimers Dement (N Y). 2018 Jul 12;4:765-774. doi:10.1016/j.trci.2018.06.008. eCollection 2018

9.Kobayashi R, Hayashi H, Kawakatsu S, Ishiki A, Okamura N, Arai H, Otani K. [18F]THK-5351 PET imaging in early-stage semantic variant primary progressive aphasia: a report of two cases and a literature review. BMC Neurol. 2018 Aug 8;18(1):109. doi: 10.1186/s12883-018-1115-3

10.Toyoshima K, Araki A, Tamura Y, Iritani O, Ogawa S, Kozaki K, Ebihara S, Hanyu H, Arai H, Kuzuya M, Iijima K, Sakurai T, Suzuki T, Toba K, Arai H, Akishita M, Rakugi H, Yokote K, Ito H, Awata S. Development of the Dementia Assessment Sheet for Community-based Integrated Care System 8-items, a short version of the Dementia Assessment Sheet for Community-based Integrated Care System 21-items, for the assessment of cognitive and daily functions. Geriatr Gerontol Int. 2018 Oct;18(10):1458-1462. doi: 10.1111/ggi.13512. Epub 2018 Sep 17

11.Hironori Fujiwara, Jun Yoshida, Dya Fita Dibwe, Suresh Awale, Haruka Hoshino,Hiroshi Kohama, Hiroyuki Arai, Yukitsuka Kudo, Kinzo Matsumoto Orengedokuto and san'oshashinto improve memory deficits by inhibiting aging-dependent activation of glycogen synthase kinase-3β DOI: https://doi.org/10.1016/j.jtcme.2018.12.001 Journal of Traditional and Complementary Medicine, 2018

12.Tomita N, Kojima T, Ishiki A, Ueda J, Numasaki M, Okinaga S, Akishita M, Arai H Could problem lists summarize comprehensive geriatric assessments? A nationwide cross-sectional survey on geriatricians' attitudes towards problem lists. Geriatr Gerontol Int. 2018 Dec 16. doi: 10.1111/ggi.13574. [Epub ahead of print]

13.Takamatsu Y, Fujita M, Ho GJ, Wada R, Sugama S, Takenouchi T, Waragai M, Masliah E, Hashimoto M. Motor and Nonmotor Symptoms of Parkinson's Disease:Antagonistic Pleiotropy Phenomena Derived from α-Synuclein Evolvability? Parkinsons Dis. 2018 Nov 22;2018:5789424. doi: 10.1155/2018/5789424. eCollection 2018. Review. PubMed PMID: 30595837; PubMed Central PMCID: PMC6282124.

14.Hashimoto M, Ho G, Takamatsu Y, Wada R, Sugama S, Takenouchi T, Masliah E, Waragai M. Possible Role of the Polyglutamine Elongation in Evolution of Amyloid-Related Evolvability. J Huntingtons Dis. 2018;7(4):297-307. doi:10.3233/JHD-180309. PubMed PMID: 30372687; PubMed Central PMCID: PMC6294593.

15.Hashimoto M, Ho G, Takamatsu Y, Shimizu Y, Sugama S, Takenouchi T, Waragai M, Masliah E. Evolvability and Neurodegenerative Disease: Antagonistic Pleiotropy Phenomena Derived from Amyloid Aggregates. J Parkinsons Dis. 2018;8(3):405-408. doi: 10.3233/JPD-181365. PubMed PMID: 30010144; PubMed Central PMCID: PMC6130413.

16.Waragai M, Ho G, Takamatsu Y, Shimizu Y, Sugino H, Sugama S, Takenouchi T, Masliah E, Hashimoto M. Dual-therapy strategy for modification of adiponectin receptor signaling in aging-associated chronic diseases. Drug Discov Today. 2018 Jun;23(6):1305-1311. doi: 10.1016/j.drudis.2018.05.009. Epub 2018 May 7. Review. PubMed PMID: 29747002.

17.Hashimoto M, Ho G, Sugama S, Takamatsu Y, Shimizu Y, Takenouchi T, Waragai M, Masliah E. Evolvability of Amyloidogenic Proteins in Human Brain. J Alzheimers Dis. 2018;62(1):73-83. doi: 10.3233/JAD-170894. PubMed PMID: 29439348; PubMed Central PMCID: PMC5817905.

18.Hashimoto M, Ho G, Shimizu Y, Sugama S, Takenouchi T, Waragai M, Wei J, Takamatsu Y. Potential Application of Centrifuges to Protect the CNS in Space and on Earth. Curr Alzheimer Res. 2018;15(6):544-551. doi:10.2174/ 1567205015666171229225501. PubMed PMID: 29298650.